Discoid lupus erythematosus (DLE) accounts for 50–80% of all cases of chronic cutaneous lupus, making it the most common subtype. The diagnosis is primarily clinical but is supported by histopathology and direct immunofluorescence in atypical or treatment-resistant cases. Clinical mimicry poses a challenge and requires consideration of a broad spectrum of differential diagnoses. Although DLE is traditionally considered a disease limited to the skin, recent findings point to potential systemic autoimmune activity, for which there were also indications in the present case.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Cellular and Systemic Iron Homeostasis
“Steady State” – a delicately balanced equilibrium
- Psychedelic-assisted therapy
Current status of PAT
- First-line treatment for T2D